Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

Proposed Operation Warp Speed for Alzheimer’s: an acceleration fund to fast-track cures and slash trillion-dollar costs.

Skye Bioscience, Inc. (Nasdaq: SKYE) ('Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic ...

Among patients with relapsed or refractory multiple myeloma, Tecvayli (teclistamab-cqyv) monotherapy was associated with a 71 ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in ...

New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the ...

The prevalence of serious inflammatory safety issues such as cytokine release syndrome and immune effector cell–associated ...

AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, announced today that the first ...

Fentanyl does not need much room to kill. A dose the size of a few grains of salt can slow breathing until it stops. The drug is up to 100 times more potent than morphine. Mixed invisibly into pills ...